Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating tegoprazan for erosive reflux disease with nighttime heartburn and sleep disturbance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Reflux Disease

Drugs mentioned

• Tegoprazan (tegoprazan)

Snippet

Sponsor: HK inno.N Corporation | Conditions: Erosive Reflux Disease | Phase 4 | Status: COMPLETED